Stockreport

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand [Yahoo! Finance]

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF EMERYVILLE, Calif., November 15, 2024 BUSINESS WIRE NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that the largest institu [Read more]